Latest Announcements

Capri Global Capital Limited has informed the Exchange about the schedule of an analyst/institutional investor meeting, which will be held from November 13 to December 1, 2026, through virtual and in-person meetings in India, Singapore, Hong Kong, and the US.

Capri Global Capital Ltd has informed about an analyst/institutional investor meeting under SEBI regulations. The meeting will be held through virtual and in-person interactions from November 13 to December 1, 2026, covering various locations in India, Singapore, Hong Kong, US, and UK. No unpublished price-sensitive information will be shared during the meeting.

Capri Global Capital Ltd has informed that the representatives of the company will be interacting with analysts and institutional investors through investor calls, virtual meetings, and physical meetings from November 13, 2026, to December 1, 2026, as per the attached schedule.

Aarti Drugs Ltd reported Q2 FY27 earnings, with total consolidated revenue at Rs. 829 crores, a 27% increase from the previous year. Operating environment remained supportive, with API prices firm across the industry. The company delivered a 16% improvement in realizations year-on-year alongside a volume growth of 5%. EBITDA grew 63% to Rs. 138 crores, with an EBITDA margin of 16.6%, up 370 basis points year-on-year.

Aarti Drugs Limited has announced its Q2 and H1 FY27 earnings, with total consolidated revenue reaching Rs. 829 crores, a 27% increase from the previous year. Operating environment remained supportive, with API prices firm due to developments in West Asia. The company delivered a 16% improvement in realizations year-on-year alongside a volume growth of 5%. EBITDA grew 63% to Rs. 138 crores, with the EBITDA margin reaching 16.6%, the highest in nearly 6 years. Profit after tax rose 83% to Rs. 83 crores.

Capri Global Capital Ltd has announced an investor meet schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will interact with analysts and institutional investors through virtual and in-person meetings from November 13 to December 1, 2026. No unpublished price-sensitive information will be shared during these meetings.

Capri Global Capital Ltd has announced an investor meet schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will interact with analysts and institutional investors through virtual meetings, physical meetings, and group meetings from November 13, 2026, to December 1, 2026. The meetings will be held in different parts of India, Singapore, Hong Kong, the US, and the UK. No unpublished price-sensitive information will be shared during the meetings.

Capri Global Capital Ltd has announced an investor meet schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will interact with analysts and institutional investors through virtual and in-person meetings from November 13 to December 1, 2026, subject to market conditions.

Capri Global Capital Ltd has informed about an analyst/institutional investor meeting under SEBI regulations. The meeting will be held through virtual and in-person interactions with analysts and institutional investors in India and abroad from November 13 to December 1, 2026. No unpublished price-sensitive information will be shared during the meeting.

B&B Realty Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve the Unaudited Financial Results for the quarter and half year ended on September 30, 2026.

Capri Global Capital Ltd has announced an investor meet schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will interact with analysts and institutional investors through virtual and in-person meetings from November 13 to December 1, 2026. No unpublished price-sensitive information will be shared during these meetings.

Capri Global Capital Limited has informed the Exchange about the schedule of its analyst/institutional investor meet/con. call updates, which will commence on November 13, 2026, and continue until December 1, 2026, subject to market conditions.

Capri Global Capital Limited has informed the Exchange about the schedule of an analyst/institutional investor meeting, which will commence on November 13, 2026, and continue until December 1, 2026, subject to market conditions.

Capri Global Capital Limited has informed the Exchange about Schedule of meet for analysts/institutional investor meetings, to be held from November 13 to December 1, 2026, with no unpublished price sensitive information to be shared.

Capri Global Capital Ltd has announced an investor meet schedule under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will interact with analysts and institutional investors through virtual and in-person meetings from November 13 to December 1, 2026, subject to market conditions.

Capri Global Capital Ltd has announced an investor meet schedule under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will interact with analysts and institutional investors through virtual and physical meetings from November 13, 2026, to December 1, 2026, subject to market conditions.

KPI Green Energy Limited has revised the timing of its Analysts/ Investors Earnings Conference Call. The conference call will now be held on Friday, November 13, 2026, at 4:30 P.M. (IST) instead of 02:30 P.M. (IST).

Capri Global Capital Ltd has informed about an analyst/institutional investor meeting under SEBI regulations. The meeting will be held through virtual and in-person interactions with analysts and institutional investors from November 13 to December 1, 2026, subject to market conditions. No unpublished price-sensitive information will be shared during the meeting.

Capri Global Capital Ltd has informed about the schedule of analyst/institutional investor meeting under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Suraksha Diagnostic Ltd announced its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors. The results are available on the company's website and have been made available to the stock exchanges.